Articles les plus consultés

jeudi 26 avril 2018

Aerie Pharmaceuticals to Announce First Quarter 2018 Financial Results and Host Conference Call on Tuesday, May 8, 2018 | Business Wire

Aerie Pharmaceuticals to Announce First Quarter 2018 Financial Results and Host Conference Call on Tuesday, May 8, 2018 | Business Wire: Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie or the Company), announced today that its first quarter 2018 financial results will be released after

Alexion Reports First Quarter 2018 Results and Positive Topline Data from ALXN1210 Phase 3 PNH Switch Study | Business Wire

Alexion Reports First Quarter 2018 Results and Positive Topline Data from ALXN1210 Phase 3 PNH Switch Study | Business Wire: Alexion Reports First Quarter 2018 Results and Positive Topline Data from ALXN1210 Phase 3 PNH Switch Study

Agence européenne des médicaments - Trouver des médicaments - Stribild

Agence européenne des médicaments - Trouver des médicaments - Stribild: Agence européenne des médicaments - Trouver des médicaments - Stribild

Amarin To Report First Quarter 2018 Results and Host Conference Call On May 2, 2018

Amarin To Report First Quarter 2018 Results and Host Conference Call On May 2, 2018

Innovus Pharma Announces the Launch of its Hemorrhoid Drug Xyralid® in Canada | Business Wire

Innovus Pharma Announces the Launch of its Hemorrhoid Drug Xyralid® in Canada | Business Wire: Innovus Pharmaceuticals, Inc. (

UMICORE

La tendance est haussière

Stratégie du 26/04/2018 | 10:09
ACHAT
En cours
Cours d'entrée : 42.77€ | Objectif : 46€ | Stop : 41.1€ | Potentiel : 7.55%
La valeur Umicore présente une configuration technique positive qui suggère de prendre le train de la hausse.
On pourra se positionner à l'achat pour viser les 46 €.

BONJOUR......EUROPACOR



Europacorp est toujours entourée $ECP Prise d'appui sur 2.80€ ce matin, résistance à 3.05€ et 3.15€ .
..HIER LE 24/04/2018